No. However, researchers are currently looking into to the connection between 9/11 toxic dust exposure and various autoimmune diseases. A 2015 study concluded that rheumatoid arthritis was the most common autoimmune diagnosis (37% of subjects), followed by spondyloarthritis (22%), inflammatory myositis (14%), systemic lupus erythematosus (12%), systemic sclerosis (5%), Sjögren’s syndrome (5%), antiphospholipid syndrome (3%), and granulomatosis with polyangiitis (Wegener’s) (2%). While this particular study concluded that “prolonged work at the WTC site, independent of acute exposure, was an important predictor of post‐9/11 systemic autoimmune diseases,” currently these conditions are still not covered by either the World Trade Center Health Program (WTCHP) or the September 11th Victim Compensation Fund (VCF).
The WTCHP has a mechanism in place that allows for the addition of new conditions as scientific evidence builds up. This process primarily relies on the research performed by the WTCHP and there will be a major program-wide change if the decision is ever made to add autoimmune diseases. For more information as to how the process to add non-cancer conditions works, click here.
This is a very common questions and many of our clients suffer from autoimmune disease that we believe is linked to their 9/11 toxic dust exposure. We are cautiously optimistic that over time, enough evidence will become available to add autoimmune diseases to the official list of covered conditions. This data pool is increased as more patients who have autoimmune disease come forward and enroll in the World Trade Center Health Program.